Physician profile
Robert Blakeburn
NPI 1164419560
$1,129.51
in general payments reported to CMS, 2019-2025
20 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $41.88 · 2021: $45.52 · 2022: $164 · 2023: $34.28 · 2024: $123 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $145.34 | 2022 | |
| Abbvie INC. | $141.33 | 2021-2025 | Vraylar |
| Novo Nordisk INC | $136.78 | 2019-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.33 | 2019-2025 | Xifaxan |
| Viatris Specialty LLC | $79.93 | 2025 | Yupelri |
| Janssen Pharmaceuticals, INC | $75.95 | 2019 | |
| Lilly USA, LLC | $65.09 | 2022-2025 | Zepbound, Kisunla |
| Bayer Healthcare Pharmaceuticals INC. | $49.12 | 2025 | |
| Pfizer INC. | $41.11 | 2020-2025 | |
| Nevro Corp. | $40.52 | 2021-2024 | Senza |
| Astrazeneca Pharmaceuticals Lp | $35.39 | 2019-2025 | Airsupra |
| Exact Sciences Corporation | $35.37 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $33.75 | 2021-2025 | Evenity |
| Merck Sharp & Dohme LLC | $29.34 | 2024-2025 | Capvaxive, Vaqta, M-M-R II |
| Takeda Pharmaceuticals U.S.A., INC. | $28.27 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $24.25 | 2025 | Inspire |
| Baxter Healthcare | $21.65 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Novartis Pharmaceuticals Corporation | $18.34 | 2019 | |
| Glaxosmithkline, LLC. | $18.23 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Eisai INC. | $14.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Blakeburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.